Antibodies Could Prove Key To Preventing Migraine
Migraine headaches affect millions of individuals worldwide with an estimated 30 million migraine sufferers in the U.S. alone. Despite that high prevalence only a limited number of effective treatment options for migraine currently exist, which include nonsteroidal anti-inflammatory drugs (NSAIDs) and triptans (5-HTIB/1D agonists).
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter